JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deloire, M S A
Right arrow Articles by Brochet, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deloire, M S A
Right arrow Articles by Brochet, B
Journal of Neurology Neurosurgery and Psychiatry 2005;76:519-526
© 2005 BMJ Publishing Group Ltd


PAPER

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

M S A Deloire1,*, E Salort1,*, M Bonnet1,*, Y Arimone3, M Boudineau1, H Amieva2, B Barroso1, J-C Ouallet1, C Pachai4, E Galliaud1, K G Petry1, V Dousset1, C Fabrigoule2, B Brochet1

1 EA 2966 Neurobiology of Myelin Disorders Laboratory, University Victor Segalen, and Department of Neurology, CHU Bordeaux, France
2 INSERM U593, University Victor Segalen
3 Department of Pharmacology, University Victor Segalen
4 Theralys Inc, Lyon, France

Correspondence to:
Correspondence to:
Professor Bruno Brochet
EA 2966 Neurobiology of Myelin Disorders Laboratory, University Victor Segalen, case 78, 146 rue Léo Saignat, 33076 Bordeaux cedex, France; bruno.brochet{at}chu-bordeaux.fr

Objectives: To establish the frequency of cognitive impairment in a population based sample of patients with recently diagnosed relapsing-remitting multiple sclerosis (RRMS), and to determine the relation between cognitive abnormalities and the extent of macroscopic and microscopic tissue damage revealed by magnetic resonance imaging (MRI) and magnetisation transfer (MT) imaging.

Methods: 58 patients with RRMS consecutively diagnosed in the previous six months in Aquitaine and 70 healthy controls underwent a battery of neuropsychological tests. Lesion load and atrophy indices (brain parenchymal fraction and ventricular fraction) were measured on brain MRI. MT ratio (MTR) histograms were obtained from lesions, normal appearing white matter (NAWM), and normal appearing grey matter (NAGM). Gadolinium enhanced lesions were counted.

Results: 44 RRMS patients could be individually matched with healthy controls for age, sex, and education. Patients performed worse in tests of verbal and spatial memory, attention, information processing speed, inhibition, and conceptualisation. Measures of attention and information processing speed were correlated with lesion load, mean NAWM MTR, and the peak location of the NAGM MTR histogram in the patients. Multivariate regression analysis showed that lesion load and mean NAWM MTR were among the MR indices that were most significantly associated with impairment of attention and information processing speed in these early RRMS cases.

Conclusions: Cognitive impairment appears to be common in the early stages of RRMS, mainly affecting attention, information processing speed, memory, inhibition, and conceptualisation. The severity of these deficits reflects the extent of the lesions and the severity of tissue disorganisation outside lesions.


Abbreviations: BNT, Boston naming test; BRB, brief repeatable battery; EDSS, expanded disability status scale; FLAIR, fast fluid attenuated inversion-recovery; ICC, intracranial cavity; MADRS, Montgomery and Asberg depression rating scale; MI, mutual information; MSFC, multiple sclerosis functional composite; MTR, magnetisation transfer ratio; NAGM, normal appearing grey matter; NAWM, normal appearing white matter; NHPT, nine hole peg test; PASAT, paced auditory serial addition test; QOL, quality of life; RFF, Ruff figural fluency test; RRMS, relapsing-remitting multiple sclerosis; SDMT, symbol digit modalities test; SRT, selective reminding test; TWT, timed 25 foot walking test; UKNDS, United Kingdom neurological disability scale; WAIS-R, Wechsler adult intelligence scale, revised; WLG, word list generation test

Keywords: multiple sclerosis; cognition; magnetic resonance imaging; magnetisation transfer imaging




This article has been cited by other articles:


Home page
Mult SclerHome page
B Audoin, F Reuter, M. Duong, I Malikova, S Confort-Gouny, A. Cherif, P. Cozzone, J Pelletier, and J. Ranjeva
Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study
Multiple Sclerosis, July 1, 2008; 14(6): 786 - 792.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
X Lin, C R Tench, P S Morgan, and C S Constantinescu
Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 437 - 441.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. Woolmore, M. Stone, S. Holley, P. Jenkinson, A. Ike, P. Jones, A. Fryer, R. Strange, R. Stephens, D. Langdon, et al.
Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis
Multiple Sclerosis, March 1, 2008; 14(2): 177 - 182.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron
Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Multiple Sclerosis, March 1, 2008; 14(2): 197 - 204.
[Abstract] [PDF]


Home page
NeurologyHome page
M. K. Houtchens, R.H.B. Benedict, R. Killiany, J. Sharma, Z. Jaisani, B. Singh, B. Weinstock-Guttman, C. R.G. Guttmann, and R. Bakshi
Thalamic atrophy and cognition in multiple sclerosis
Neurology, September 18, 2007; 69(12): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. P. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini, M. L. Bartolozzi, M. L. Stromillo, L. Guidi, G. Siracusa, S. Sorbi, et al.
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Arch Neurol, August 1, 2007; 64(8): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Viswanathan, A. Gschwendtner, J. -P. Guichard, F. Buffon, R. Cumurciuc, M. O'Sullivan, M. Holtmannspotter, C. Pachai, M. -G. Bousser, M. Dichgans, et al.
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL
Neurology, July 10, 2007; 69(2): 172 - 179.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
L Feuillet, F Reuter, B Audoin, I Malikova, K Barrau, A A. Cherif, and J Pelletier
Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis
Multiple Sclerosis, January 1, 2007; 13(1): 124 - 127.
[Abstract] [PDF]


Home page
BrainHome page
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al.
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study
Brain, September 1, 2006; 129(9): 2375 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
H Hildebrandt, H K Hahn, J A Kraus, A Schulte-Herbruggen, B Schwarze, and G Schwendemann
Memory performance in multiple sclerosis patients correlates with central brain atrophy
Multiple Sclerosis, August 1, 2006; 12(4): 428 - 436.
[Abstract] [PDF]


Home page
Mult SclerHome page
S D Brass, R H. Benedict, B Weinstock-Guttman, F Munschauer, and R Bakshi
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis
Multiple Sclerosis, August 1, 2006; 12(4): 437 - 444.
[Abstract] [PDF]


Home page
Mult SclerHome page
M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet
How to detect cognitive dysfunction at early stages of multiple sclerosis?
Multiple Sclerosis, August 1, 2006; 12(4): 445 - 452.
[Abstract] [PDF]


Home page
NeurologyHome page
M. D. Hill and J. R. Mitchell
White matter lesions and cognition: It's time for randomized trials to preserve intelligence
Neurology, February 28, 2006; 66(4): 470 - 471.
[Full Text] [PDF]


Home page
NeurologyHome page
I. J. Deary, M. E. Bastin, A. Pattie, J. D. Clayden, L. J. Whalley, J. M. Starr, and J. M. Wardlaw
White matter integrity and cognition in childhood and old age
Neurology, February 28, 2006; 66(4): 505 - 512.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.